医源性儿童羟钴胺过量一例
本文报告一例3岁健康女童从公寓火灾中被救出后由院前人员择期插管,因担心氰化物中毒接受5 g(373 mg/kg)静脉羟钴胺,相当于一个标准成人剂量,是该13.4 kg儿童体重调整剂量的5倍以上。到院时出现色尿和弥漫性红斑,无皮肤烧伤;插管后4小时拔管,次晨出院,一般情况良好,红斑持续但2天内肤色恢复正常。作者认为这是首例医源性儿童羟钴胺过量病例;红斑和色尿即使治疗剂量也可出现,唯一其他发现是插管后短暂且血流动力学中性的心动过缓,因发生于给药前,更可能源于喉镜刺激迷走神经和重复琥珀胆碱的窦房结毒蕈碱受体激动。作者未能发现过量羟钴胺导致的任何并发症。
要点
- 3岁13.4 kg女童因疑似氰化物中毒接受5 g(373 mg/kg)静脉羟钴胺,超过体重调整剂量5倍以上。
- 到院时表现为色尿和弥漫性红斑,无皮肤烧伤是唯一体征。
- 插管后4小时拔管,次晨出院,一般情况良好,红斑持续但2天内肤色恢复正常。
- 短暂且血流动力学中性的心动过缓发生于羟钴胺给药前,更可能源于喉镜迷走刺激或重复琥珀胆碱。
- 作者未能发现任何由过量羟钴胺导致的并发症。
适用人群与场景
- 从密闭空间火灾中被救出、担心吸入性损伤和潜在氰化物中毒的儿童患者(本例为3岁健康女童,13.4 kg)。
处置流程与药物剂量
- 院前因担心潜在氰化物中毒,经静脉给予羟钴胺5 g(373 mg/kg),相当于一个标准成人剂量,是该13.4 kg儿童体重调整剂量的5倍以上。
红旗征与不能漏的情况
- 色尿和弥漫性红斑是羟钴胺即使治疗剂量也可出现的预期副作用。
- 插管后短暂且血流动力学中性的心动过缓,因发生于羟钴胺给药前,更可能源于直接喉镜的迷走神经刺激和重复琥珀胆碱的窦房结毒蕈碱受体激动。
研究设计与关键结果
- 病例报告:3岁健康女童从公寓火灾中被救出,由院前人员择期插管,因担心潜在氰化物中毒接受5 g(373 mg/kg)静脉羟钴胺,超过体重调整剂量5倍以上。
- 到院时发现色尿和弥漫性红斑,无皮肤烧伤;插管后4小时拔管,次晨出院,一般情况良好,红斑持续但2天内肤色恢复正常。
- 作者认为这是首例医源性儿童羟钴胺过量用于治疗疑似氰化物中毒的报道,未能发现任何由过量羟钴胺导致的并发症。
证据类型、等级与局限
- 病例报告。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这是首例医源性儿童羟钴胺过量病例,红斑和色尿是羟钴胺即使治疗剂量也可出现的预期副作用,未能发现任何由过量羟钴胺导致的并发症。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Hydroxocobalamin, a precursor molecule to vitamin B12, has emerged as the preferred empiric treatment for patients rescued from enclosed-space fires with concern for inhalational injury and potential concomitant cyanide toxicity. Limited data exist on the effects of hydroxocobalamin toxicity, particularly in pediatric patients.
CASE REPORT: We report a case of a healthy three-year old girl who was rescued from an apartment fire and electively intubated by prehospital providers. Due to concern for potential cyanide toxicity, she received 5 g (373 mg/kg) of intravenous hydroxocobalamin, an amount equivalent to one standard adult dose but over five times the appropriate weight-adjusted dose for this 13.4-kilogram child. On hospital arrival, patient was noted to have chromaturia and diffuse erythroderma without cutaneous burns. She was extubated 4 h after prehospital intubation and discharged home the following morning in good condition with persistent erythroderma. Skin color returned to normal within two days.
DISCUSSION: We believe this to be the first reported case of iatrogenic pediatric hydroxocobalamin overdose for the treatment of suspected cyanide toxicity. Erythroderma and chromaturia are expected side effects of hydroxocobalamin, even at therapeutic levels. Along with minor airway burns, the only other finding was a transient and hemodynamically neutral bradycardia, which began shortly after prehospital intubation. As this bradycardia occurred prior to hydroxocobalamin administration, more likely culprits include vagal nerve stimulation from direct laryngoscopy, and sinoatrial muscarinic receptor stimulation caused by repeated doses of succinylcholine. In all, we were unable to appreciate any complications due to excess hydroxocobalamin administration.
参考来源
- Friedman BT, Chen BC, Latimer AJ, et al. Iatrogenic pediatric hydroxocobalamin overdose. Am J Emerg Med. 2019. PMID: 31000316. doi:10.1016/j.ajem.2019.04.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。